The Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine Users (NCT07532460) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine Users
Switzerland40 participantsStarted 2026-04
Plain-language summary
The study aims to address the neurobiological basis of cognitive impairments in chronic cocaine users by investigating the potential impact of an acute potassium channel blockade on working memory performance and other cognitive functions.
Who can participate
Age range20 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Current diagnosis of mild, moderate, or severe CoUD according to DSM-5
* Minimum cocaine use of 1g/month in the last three months
* Cocaine as the primary drug of consumption
* Willingness to abstain from cocaine use at least 72 hours before prior to each study visit
* Ability to read, understand and provide written informed consent
* To be sufficiently fluent in German
* Age between 20 and 50 years
* Body mass index (BMI) between 19 and 30 kg/m2
* If applicable: luteal phase of the menstrual cycle
* For individuals with childbearing potential: use of contraceptive measures
Exclusion Criteria:
* Presence or history of severe neurological disorders or head injuries
* Current diagnosis of an acute or chronic infectious disease
* If applicable: pregnancy and breastfeeding
* Lifetime history of any epileptic seizures
* Lifetime diagnosis of a cardiovascular disease, specifically arrhythmia and long QT syndrome
* Clinically significant laboratory or ECG abnormality that could be a safety issue in the study
* Lifetime diagnosis of liver or kidney disease including moderate or severe renal impairment (creatinine clearance \< 50 ml/min)
* Known hypersensitivity or allergy to 4-aminopyridine
* Use of potassium channel blockers within the last 3 months
* Use of psychotropic medication within the last 7 days
* Use of inhibitors of the organic cation transporter 2 (OCT2), such as cimetidine
* Lifetime diagnosis of schizophrenia, bipolar disorder, obsessive-compul…
What they're measuring
1
Global Working Memory Performance
Timeframe: Baseline and during both experimental sessions
Trial details
NCT IDNCT07532460
SponsorBoris Quednow
Sponsor typeOTHER
Study typeINTERVENTIONAL
Primary completion2027-08
Contact for this trial
Prof. Dr. rer. nat. Boris B. Quednow, Dr. rer. nat.